ARTICLE | Clinical News
AB0024: Phase I data
September 13, 2010 7:00 AM UTC
In a dose-escalation Phase I trial in 3 patients, 1 mg/kg AB0024 every 2 weeks was well tolerated. An additional 3 patients are being enrolled at the 3 mg/kg dose level. Arresto plans to begin a Phase...